The extension of our cohort to now 636 patients with clinical follow-up data undergoing cystectomy for muscle-invasive urothelial cancer did not suggest a prognostic role of Upk1a/1b expression in analyses involving the entire cohort but lead to data that suggest a complex relationship between uroplakin expression and tumor aggressiveness. This evidence concerns the gene UPK1A and neoplasm.